TY - JOUR
T1 - Shared motherhood IVF
T2 - high delivery rates in a large study of treatments for lesbian couples using partner-donated eggs
AU - Bodri, D.
AU - Nair, S.
AU - Gill, A.
AU - Lamanna, G.
AU - Rahmati, M.
AU - Arian-Schad, M.
AU - Smith, V.
AU - Linara, E.
AU - Wang, J.
AU - Macklon, N.
AU - Ahuja, K. K.
PY - 2018/2
Y1 - 2018/2
N2 - Shared motherhood IVF treatment is becoming increasingly accepted among assisted reproductive techique practitioners and patients in Europe, although data on its overall efficiency remain scarce. This 6-year retrospective study from a single, private, UK HFEA-regulated centre included consecutive lesbian couples (n = 121) undergoing shared motherhood IVF treatment (141 cycles). Recipients were more parous and had undergone more previous intrauterine insemination and IVF treatments than donor partners, who had slightly higher ovarian reserve markers than recipients. Indications in most cycles (60%) were non-medical. Most (79%) egg-providers were stimulated with gonadotrophin releasing hormone antagonist protocol, and no moderate or severe cases of ovarian hyperstimulation syndrome (OHSS) arose. A total of 172 fresh and vitrified-warmed embryo transfers were carried out: 70% at the blastocyst-stage and 58% involved a single embryo. Cumulative live birth rate per receiver was 60% (72/120), and twin delivery rate was 14% (10/72). Perinatal outcome parameters were better for singleton than twin pregnancies, although the latter also achieved generally favourable outcomes. No significant difference in cumulative outcomes were found between synchronized and non-synchronized cycles. Shared motherhood IVF combines ovarian stimulation with single blastocyst transfer to provide a safe and effective treatment modality offering reassuring obstetrical and perinatal outcomes.
AB - Shared motherhood IVF treatment is becoming increasingly accepted among assisted reproductive techique practitioners and patients in Europe, although data on its overall efficiency remain scarce. This 6-year retrospective study from a single, private, UK HFEA-regulated centre included consecutive lesbian couples (n = 121) undergoing shared motherhood IVF treatment (141 cycles). Recipients were more parous and had undergone more previous intrauterine insemination and IVF treatments than donor partners, who had slightly higher ovarian reserve markers than recipients. Indications in most cycles (60%) were non-medical. Most (79%) egg-providers were stimulated with gonadotrophin releasing hormone antagonist protocol, and no moderate or severe cases of ovarian hyperstimulation syndrome (OHSS) arose. A total of 172 fresh and vitrified-warmed embryo transfers were carried out: 70% at the blastocyst-stage and 58% involved a single embryo. Cumulative live birth rate per receiver was 60% (72/120), and twin delivery rate was 14% (10/72). Perinatal outcome parameters were better for singleton than twin pregnancies, although the latter also achieved generally favourable outcomes. No significant difference in cumulative outcomes were found between synchronized and non-synchronized cycles. Shared motherhood IVF combines ovarian stimulation with single blastocyst transfer to provide a safe and effective treatment modality offering reassuring obstetrical and perinatal outcomes.
KW - In-vitro fertilization
KW - Lesbian couples
KW - Oocyte donation
KW - Shared motherhood IVF
KW - Single embryo transfer
UR - http://www.scopus.com/inward/record.url?scp=85038351802&partnerID=8YFLogxK
U2 - 10.1016/j.rbmo.2017.11.006
DO - 10.1016/j.rbmo.2017.11.006
M3 - Article
C2 - 29269265
AN - SCOPUS:85038351802
SN - 1472-6483
VL - 36
SP - 130
EP - 136
JO - Reproductive BioMedicine Online
JF - Reproductive BioMedicine Online
IS - 2
ER -